DMIIU — Drugs Made In America Acquisition II Corp. Unit
NASDAQ
$10.20
+$0.03 (+0.29%)
Drugs Made In America Acquisition II Corp. Unit (DMIIU) common stock listed on NASDAQ. Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Net income was -$46.2K.
Use this DMIIU page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DMIIU quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DMIIU SEC filings page. Lician reads the product cache first so this HTML stays unique to Drugs Made In America Acquisition II Corp. Unit even when a live quote feed is slow.
About Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
DMIIU Key Statistics
Market Cap
$0.00M
Volume
33
Previous Close
$10.20
Day Range
$10.20 – $10.20
EPS
$0.00
Revenue
$0.00
Net Income
-$46.16K
Gross Profit
$0.00
Free Cash Flow
$0.00
DMIIU Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2025 | FY2025 | FY2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$46.16K | -$38.07K | -$59.33K | -$41.68K |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Total Assets
$501.01M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$315.09K
Operating Cash Flow
-$703.37K
Free Cash Flow
$0.00
Drugs Made In America Acquisition II Corp. Unit Company Information
- IPO / Founded
- 2025-09-25